SEC Filing: Stock Option Grant to Chief Operating Officer at Apyx Medical Corp

This SEC filing details a stock option grant to Shawn David Roman, the Chief Operating Officer of Apyx Medical Corp. The grant, dated June 11, 2026, includes 88,044 stock options for Common Stock with a nominal purchase price of $0.00. These options are subject to a vesting schedule, with full vesting occurring on the third anniversary of the grant date. The options have an exercise price of $4.65 and an expiration date of June 11, 2036. The filing indicates that this transaction is a direct ownership acquisition by the reporting person.